Pathogenesis of neurodegenerative diseases associated with expanded glutamine repeats: new answers, new questions.

[1]  Christopher A. Ross,et al.  Atrophin-1, the DRPLA Gene Product, Interacts with Two Families of WW Domain-Containing Proteins , 1998, Molecular and Cellular Neuroscience.

[2]  C A Ross,et al.  Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. , 1998, Human molecular genetics.

[3]  S. W. Davies,et al.  Intranuclear Neuronal Inclusions in Huntington's Disease and Dentatorubral and Pallidoluysian Atrophy: Correlation between the Density of Inclusions andIT15CAG Triplet Repeat Length , 1998, Neurobiology of Disease.

[4]  T. Wisniewski,et al.  Biology of Aβ Amyloid in Alzheimer's Disease , 1997, Neurobiology of Disease.

[5]  K. Fischbeck,et al.  Characterization of an Expanded Glutamine Repeat Androgen Receptor in a Neuronal Cell Culture System , 1997, Neurobiology of Disease.

[6]  R. Albin,et al.  Ectopically Expressed CAG Repeats Cause Intranuclear Inclusions and a Progressive Late Onset Neurological Phenotype in the Mouse , 1997, Cell.

[7]  Jacqueline K. White,et al.  Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion , 1997, Nature Genetics.

[8]  C A Ross,et al.  Intranuclear Neuronal Inclusions: A Common Pathogenic Mechanism for Glutamine-Repeat Neurodegenerative Diseases? , 1997, Neuron.

[9]  P. Worley,et al.  Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin. , 1997, Human molecular genetics.

[10]  Y. Okamura-Oho,et al.  Dentatorubral Pallidoluysian Atrophy (DRPLA) Protein Is Cleaved by Caspase-3 during Apoptosis* , 1997, The Journal of Biological Chemistry.

[11]  T Tukamoto,et al.  Huntington's disease gene product, huntingtin, associates with microtubules in vitro. , 1997, Brain research. Molecular brain research.

[12]  M. Hayden,et al.  Rethinking genotype and phenotype correlations in polyglutamine expansion disorders. , 1997, Human molecular genetics.

[13]  H. Zoghbi,et al.  The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1 , 1997, Nature.

[14]  H. Zoghbi,et al.  Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures , 1997, Nature.

[15]  S A Kuznetsov,et al.  The interaction between cytoplasmic dynein and dynactin is required for fast axonal transport. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Penney,et al.  Huntingtin localization in brains of normal and Huntington's disease patients , 1997, Annals of neurology.

[17]  H. Zoghbi,et al.  Purkinje Cell Expression of a Mutant Allele of SCA1in Transgenic Mice Leads to Disparate Effects on Motor Behaviors, Followed by a Progressive Cerebellar Dysfunction and Histological Alterations , 1997, The Journal of Neuroscience.

[18]  S. W. Davies,et al.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. , 1997, Science.

[19]  E. Aylward,et al.  Huntington disease and the related disorder, dentatorubral-pallidoluysian atrophy (DRPLA). , 1997, Medicine.

[20]  P. Worley,et al.  Huntingtin-associated protein 1 (HAP1) binds to a Trio-like polypeptide, with a rac1 guanine nucleotide exchange factor domain. , 1997, Human molecular genetics.

[21]  Hans Lehrach,et al.  Huntingtin-Encoded Polyglutamine Expansions Form Amyloid-like Protein Aggregates In Vitro and In Vivo , 1997, Cell.

[22]  R. Vallee,et al.  Fast transport and retrograde movement of huntingtin and HAP 1 in axons , 1997, Neuroreport.

[23]  M. Beal,et al.  Iodoacetate Produces Striatal Excitotoxic Lesions , 1997, Journal of neurochemistry.

[24]  C. Ross,et al.  Huntington's Disease and Dentatorubral‐Pallidoluysian Atrophy: Proteins, Pathogenesis and Pathology , 1997, Brain pathology.

[25]  M. Porteous,et al.  Dentatorubral and pallidoluysian atrophy (DRPLA) Clinical and neuropathological findings in genetically confirmed north american and european pedigrees , 1997, Movement disorders : official journal of the Movement Disorder Society.

[26]  M. Nance.  Clinical Aspects of CAG Repeat Diseases , 1997, Brain pathology.

[27]  A. Clark,et al.  Inherited Neurodegenerative Disorders Caused by CAG/Polyglutamine Tract Expansions: Symposium Introduction , 1997, Brain pathology.

[28]  Í. Lopes-Cendes,et al.  The Neuropathology of CAG Repeat Diseases: Review and Update of Genetic and Molecular Features , 1997, Brain pathology.

[29]  M. McInnis,et al.  cDNAs with long CAG trinucleotide repeats from human brain , 1997, Human Genetics.

[30]  Mark Turmaine,et al.  Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation , 1997, Cell.

[31]  R. Mains,et al.  Kalirin, a Cytosolic Protein with Spectrin-like and GDP/GTP Exchange Factor-like Domains That Interacts with Peptidylglycine α-Amidating Monooxygenase, an Integral Membrane Peptide-processing Enzyme* , 1997, The Journal of Biological Chemistry.

[32]  F. Andermann,et al.  Phenotypic variability in friedreich ataxia: Role of the associated GAA triplet repeat expansion , 1997, Annals of neurology.

[33]  M. Beal,et al.  Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia , 1997, Annals of neurology.

[34]  I. Kanazawa,et al.  Regional and cellular expression of the dentatorubral‐pallidoluysian atrophy gene in brains of normal and affected individuals , 1997, Annals of neurology.

[35]  I. Kanazawa,et al.  HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain , 1997, Nature Genetics.

[36]  M. MacDonald,et al.  Heterogeneous Topographic and Cellular Distribution of Huntingtin Expression in the Normal Human Neostriatum , 1997, The Journal of Neuroscience.

[37]  K. Fischbeck,et al.  Machado‐Joseph disease gene product is a cytoplasmic protein widely expressed in brain , 1997, Annals of neurology.

[38]  M. MacDonald,et al.  The Genetic Defect Causing Huntington’s Disease: Repeated in Other Contexts? , 1997, Molecular medicine.

[39]  Richard L. Huganir,et al.  GRIP: a synaptic PDZ domain-containing protein that interacts with AMPA receptors , 1997, Nature.

[40]  H. Lehrach,et al.  HIP-I: a huntingtin interacting protein isolated by the yeast two-hybrid system. , 1997, Human molecular genetics.

[41]  S. Knight,et al.  Expression and distribution of the dentatorubral-pallidoluysian atrophy gene product (atrophin-1/drplap) in neuronal and non-neuronal tissues , 1997, Journal of the Neurological Sciences.

[42]  S. Tsuji,et al.  Molecular cloning of murine homologue dentatorubral-pallidoluysian atrophy (DRPLA) cDNA: strong conservation of a polymorphic CAG repeat in the murine gene. , 1997, Genomics.

[43]  S. Nagata,et al.  Apoptosis by Death Factor , 1997, Cell.

[44]  William B. Dobyns,et al.  Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channel , 1997, Nature Genetics.

[45]  S. Tsuji.  Molecular genetics of triplet repeats: unstable expansion of triplet repeats as a new mechanism for neurodegenerative diseases. , 1997, Internal medicine.

[46]  J. Vance,et al.  Toxicity of expanded polyglutamine‐domain proteins in Escherichia coli , 1996, FEBS letters.

[47]  M. Perutz,et al.  Glutamine repeats and inherited neurodegenerative diseases: molecular aspects. , 1996, Current opinion in structural biology.

[48]  C. Caskey,et al.  Trinucleotide repeat disorders in humans: discussions of mechanisms and medical issues , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[49]  Keisuke Kuida,et al.  Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice , 1996, Nature.

[50]  R. C. Johnson,et al.  Novel Proteins That Interact with the COOH-terminal Cytosolic Routing Determinants of an Integral Membrane Peptide-processing Enzyme* , 1996, The Journal of Biological Chemistry.

[51]  S. W. Davies,et al.  Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice , 1996, Cell.

[52]  K. Fischbeck,et al.  Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase. , 1996, Human molecular genetics.

[53]  P G Bhide,et al.  Expression of Normal and Mutant Huntingtin in the Developing Brain , 1996, The Journal of Neuroscience.

[54]  J. Hodgson,et al.  Huntingtin Is Ubiquitinated and Interacts with a Specific Ubiquitin-conjugating Enzyme* , 1996, The Journal of Biological Chemistry.

[55]  J. D. den Dunnen,et al.  Subcellular localization of the Huntington's disease gene product in cell lines by immunofluorescence and biochemical subcellular fractionation. , 1996, Human molecular genetics.

[56]  S. Narumiya,et al.  Expanded polyglutamine in the Machado–Joseph disease protein induces cell death in vitro and in vivo , 1996, Nature Genetics.

[57]  A. Debant,et al.  The multidomain protein Trio binds the LAR transmembrane tyrosine phosphatase, contains a protein kinase domain, and has separate rac-specific and rho-specific guanine nucleotide exchange factor domains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[58]  S. Snyder,et al.  Huntingtin-associated protein (HAP1): discrete neuronal localizations in the brain resemble those of neuronal nitric oxide synthase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[59]  B R Rosen,et al.  Non-Invasive Neurochemical Analysis of Focal Excitotoxic Lesions in Models of Neurodegenerative Illness Using Spectroscopic Imaging , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[60]  P S Harper,et al.  Partial characterisation of murine huntingtin and apparent variations in the subcellular localisation of huntingtin in human, mouse and rat brain. , 1996, Human molecular genetics.

[61]  P. Patel,et al.  Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion , 1996, Science.

[62]  D. Chuang,et al.  Evidence that Glyceraldehyde‐3‐Phosphate Dehydrogenase Is Involved in Age‐Induced Apoptosis in Mature Cerebellar Neurons in Culture , 1996, Journal of neurochemistry.

[63]  J. Cooper,et al.  Mitochondrial defect in Huntington's disease caudate nucleus , 1996, Annals of neurology.

[64]  G. Bates.  Expanded glutamines and neurodegeneration--a gain of insight. , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.

[65]  C. Ross,et al.  DRPLA gene (atrophin-1) sequence and mRNA expression in human brain. , 1996, Brain research. Molecular brain research.

[66]  I. Kondo,et al.  Proton magnetic resonance spectroscopy on childhood-onset dentatorubral-pallidoluysian atrophy (DRPLA) , 1996, Brain and Development.

[67]  A. Roses,et al.  Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH , 1996, Nature Medicine.

[68]  P. Wahle,et al.  cDNA cloning and expression of rsca1, the rat counterpart of the human spinocerebellar ataxia type 1 gene. , 1996, Human molecular genetics.

[69]  S Karlin,et al.  Trinucleotide repeats and long homopeptides in genes and proteins associated with nervous system disease and development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[70]  C. Ross,et al.  Neurobiology of Huntington's Disease , 1996, Neurobiology of Disease.

[71]  J. O’Kusky,et al.  Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the human Huntington disease transcript. , 1996, Human molecular genetics.

[72]  O. Suchowersky,et al.  Relationship between trinucliotide repeats and neuropathological changes in Huntington's diease , 1996, Annals of neurology.

[73]  K. Fischbeck,et al.  Trinucleotide repeats in neurogenetic disorders. , 1996, Annual review of neuroscience.

[74]  H. Zoghbi,et al.  Cloning and developmental expression analysis of the murine homolog of the spinocerebellar ataxia type 1 gene (Sca1). , 1996, Human molecular genetics.

[75]  M. MacDonald,et al.  Trinucleotide instability: a repeating theme in human inherited disorders. , 1996, Annual review of medicine.

[76]  H. Sweeney,et al.  Mutational analysis of motor proteins. , 1996, Annual review of physiology.

[77]  Y. Agid,et al.  Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias , 1995, Nature.

[78]  S. Snyder,et al.  A huntingtin-associated protein enriched in brain with implications for pathology , 1995, Nature.

[79]  K. Herholz,et al.  Neurological sequelae of cyanide intoxication — the patterns of clinical, magnetic resonance imaging, and positron emission tomography findings , 1995, Annals of neurology.

[80]  Nahida Matta,et al.  CAG expansion affects the expression of mutant huntingtin in the Huntington's disease brain , 1995, Neuron.

[81]  B. André,et al.  NPI1, an essential yeast gene involved in induced degradation of Gap1 and Fur4 permeases, encodes the Rsp5 ubiquitin—protein ligase , 1995, Molecular microbiology.

[82]  Virginia E. Papaioannou,et al.  Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue , 1995, Nature Genetics.

[83]  Harry T Orr,et al.  SCA1 transgenic mice: A model for neurodegeneration caused by an expanded CAG trinucleotide repeat , 1995, Cell.

[84]  S. Hersch,et al.  Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[85]  O. Riess,et al.  Predominant neuronal expression of the gene responsible for dentatorubral-pallidoluysian atrophy (DRPLA) in rat. , 1995, Human molecular genetics.

[86]  C A Ross,et al.  When more is less: Pathogenesis of glutamine repeat neurodegenerative diseases , 1995, Neuron.

[87]  C. Ross,et al.  Expression of the Huntington's disease (IT15) protein product in HD patients. , 1995, Human molecular genetics.

[88]  A. Joyner,et al.  Inactivation of the mouse Huntington's disease gene homolog Hdh. , 1995, Science.

[89]  M. Beal,et al.  Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[90]  M. Perutz,et al.  Incorporation of glutamine repeats makes protein oligomerize: implications for neurodegenerative diseases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[91]  S. Floresco,et al.  Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes , 1995, Cell.

[92]  Muneesh Tewari,et al.  Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase , 1995, Cell.

[93]  J Deisenhofer,et al.  Proteins with leucine-rich repeats. , 1995, Current opinion in structural biology.

[94]  C. Ross,et al.  Cloning and expression of the rat atrophin-I (DRPLA disease gene) homologue , 1995, Neurobiology of Disease.

[95]  S. Warren,et al.  Translational suppression by trinucleotide repeat expansion at FMR1 , 1995, Science.

[96]  B. Rosen,et al.  Involvement of Free Radicals in Excitotoxicity In Vivo , 1995, Journal of neurochemistry.

[97]  M. MacDonald,et al.  Normal and Expanded Huntington’s Disease Gene Alleles Produce Distinguishable Proteins Due to Translation Across the CAG Repeat , 1995, Molecular medicine.

[98]  R. Durbin,et al.  Comparative sequence analysis of the human and pufferfish Huntington's disease genes , 1995, Nature Genetics.

[99]  I. Kanazawa,et al.  Abnormal gene product identified in hereditary dentatorubral–pallidoluysian atrophy (DRPLA) brain , 1995, Nature Genetics.

[100]  D. Housman.  Gain of glutamines, gain of function? , 1995, Nature Genetics.

[101]  R. Carraway,et al.  Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons , 1995, Neuron.

[102]  Christopher A Ross,et al.  Widespread expression of Huntington's disease gene (IT15) protein product , 1995, Neuron.

[103]  L Pinsky,et al.  Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. , 1995, Human molecular genetics.

[104]  M. Scheffner,et al.  A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[105]  A. Chakravarti,et al.  Down syndrome consequent to a cryptic maternal 12p;21q chromosome translocation. , 1995, American journal of medical genetics.

[106]  R. Myers,et al.  Evidence from antibody studies that the CAG repeat in the Huntington disease gene is expressed in the protein. , 1995, Human molecular genetics.

[107]  M. MacDonald,et al.  Huntington's disease gene: Regional and cellular expression in brain of normal and affected individuals , 1995, Annals of neurology.

[108]  H. Zoghbi,et al.  Expression analysis of the ataxin–1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals , 1995, Nature Genetics.

[109]  K. Fischbeck,et al.  Trinucleotide repeat expansion in neurological disease , 1994, Annals of neurology.

[110]  M. MacDonald,et al.  Huntington's disease CAG trinucleotide repeats in pathologically confirmed post-mortem brains , 1994, Neurobiology of Disease.

[111]  M. Taoka,et al.  A nuclear factor containing the leucine-rich repeats expressed in murine cerebellar neurons. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[112]  K. Tadokoro,et al.  Structure and expression of the gene responsible for the triplet repeat disorder, dentatorubral and pallidoluysian atrophy (DRPLA) , 1994, Nature Genetics.

[113]  N. Chamberlain,et al.  The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. , 1994, Nucleic acids research.

[114]  J. Beckmann,et al.  The gene for the TATA binding protein (TBP) that contains a highly polymorphic protein coding CAG repeat maps to 6q27. , 1994, Genomics.

[115]  H Green,et al.  Codon reiteration and the evolution of proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[116]  M. MacDonald,et al.  Mouse Huntington's disease gene homolog (Hdh) , 1994, Somatic cell and molecular genetics.

[117]  S. Rusconi,et al.  Transcriptional activation modulated by homopolymeric glutamine and proline stretches. , 1994, Science.

[118]  R. Durbin,et al.  Structure and expression of the Huntington's disease gene: Evidence against simple inactivation due to an expanded CAG repeat , 1994, Somatic cell and molecular genetics.

[119]  L. Dure,et al.  Trinucleotide repeats in neurologic diseases: an hypothesis concerning the pathogenesis of Huntington's disease, Kennedy's disease, and spinocerebellar ataxia type I. , 1994, Life sciences.

[120]  B. Rosen,et al.  Evidence for irnnairment of energy metabofism in vivo in Huntington's disease using localized 1H NMR spectroscopy , 1993, Neurology.

[121]  R. Roos,et al.  Characterization and localization of the Huntington disease gene product. , 1993, Human molecular genetics.

[122]  S. Folstein,et al.  Huntington's disease gene (IT15) is widely expressed in human and rat tissues , 1993, Neuron.

[123]  R. Albin,et al.  Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues , 1993, Nature Genetics.

[124]  R. S. Williams,et al.  Evidence for neuronal degeneration and dendritic plasticity in cortical pyramidal neurons of Huntington's disease , 1993, Neurology.

[125]  J. Rommens,et al.  Differential 3' polyadenylation of the Huntington disease gene results in two mRNA species with variable tissue expression. , 1993, Human molecular genetics.

[126]  D. Nelson,et al.  Trinucleotide repeat expansions in neurological disease , 1993, Current Opinion in Neurobiology.

[127]  B. Hyman,et al.  Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[128]  H. Green.  Human genetic diseases due to codon reiteration: Relationship to an evolutionary mechanism , 1993, Cell.

[129]  J. Bockaert,et al.  NMDA-dependent superoxide production and neurotoxicity , 1993, Nature.

[130]  J. Penney,et al.  Trinucleotide repeat length instability and age of onset in Huntington's disease , 1993, Nature Genetics.

[131]  D. Drubin,et al.  Synthetic-lethal interactions identify two novel genes, SLA1 and SLA2, that control membrane cytoskeleton assembly in Saccharomyces cerevisiae , 1993, The Journal of cell biology.

[132]  M. McInnis,et al.  Genes with triplet repeats: candidate mediators of neuropsychiatric disorders , 1993, Trends in Neurosciences.

[133]  A. Adler,et al.  Androgen-specific gene activation via a consensus glucocorticoid response element is determined by interaction with nonreceptor factors. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[134]  R. Llinás,et al.  Distribution and functional significance of the P-type, voltage-dependent Ca2+ channels in the mammalian central nervous system , 1992, Trends in Neurosciences.

[135]  S H Snyder,et al.  A novel neuronal messenger molecule in brain: The free radical, nitric oxide , 1992, Annals of neurology.

[136]  S. Kumar,et al.  Identification of a set of genes with developmentally down-regulated expression in the mouse brain. , 1992, Biochemical and biophysical research communications.

[137]  R. Albin,et al.  Alternative excitotoxic hypotheses , 1992, Neurology.

[138]  H. Willard,et al.  Complete deletion of the androgen receptor gene: definition of the null phenotype of the androgen insensitivity syndrome and determination of carrier status. , 1992, The Journal of clinical endocrinology and metabolism.

[139]  J. Penney,et al.  Preferential loss of striato‐external pallidal projection neurons in presymptomatic Huntington's disease , 1992, Annals of neurology.

[140]  M. Beal,et al.  Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? , 1992, Annals of neurology.

[141]  Christopher A. Ross,et al.  Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease , 1991, Neuroscience Letters.

[142]  R. S. Williams,et al.  Morphometric analysis of the prefrontal cortex in Huntington's disease , 1991, Neurology.

[143]  L. Farrer,et al.  Homozygote for Huntington disease. , 1989, American journal of human genetics.

[144]  Joseph B. Martin,et al.  Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease , 1987, Brain Research.

[145]  D. Duboule,et al.  DNA sequences homologous to the Drosophila opa repeat are present in murine mRNAs that are differentially expressed in fetuses and adult tissues , 1987, Molecular and cellular biology.

[146]  J. Penney,et al.  Homozygotes for Huntington's disease , 1987, Nature.

[147]  Joseph B. Martin,et al.  Patterns of cell loss in Huntington's disease , 1987, Trends in Neurosciences.

[148]  Joseph B. Martin,et al.  Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid , 1986, Nature.

[149]  J. B. Martin,et al.  Selective sparing of a class of striatal neurons in Huntington's disease. , 1985, Science.

[150]  R. Ferrante,et al.  Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.

[151]  G. Graveland,et al.  A Golgi study of the human neostriatum: Neurons and afferent fibers , 1985, The Journal of comparative neurology.

[152]  S. Artavanis-Tsakonas,et al.  opa: A novel family of transcribed repeats shared by the Notch locus and other developmentally regulated loci in D. melanogaster , 1985, Cell.

[153]  G. Legler,et al.  Active site‐directed inhibition of galactosidases by conduritol C epoxides (1,2‐anhydro‐EPI‐and NEO‐inositol , 1981, FEBS letters.

[154]  L. Roizin.  The relevance of the structural co-factor (chemogenic lesion) in adverse and toxic reactions of neuropsychotropic agents. , 1979, Progress in neuro-psychopharmacology.

[155]  M. Sar,et al.  Androgen concentration in motor neurons of cranial nerves and spinal cord. , 1977, Science.